Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Yap FB et al. Penicillium marneffei infection in an African man. 2010 Dermatol. Online J. pmid:20673530
Sakeer K et al. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. 2010 Arch. Pharm. Res. pmid:21116780
Raghu H et al. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells. 2010 BMC Cancer pmid:21106094
Schilling T and Eder C Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. 2010 Cell. Immunol. pmid:20832779
Tempark T et al. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. 2010 Endocrine pmid:20972726
Kolter R Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology. 2010 Int. Microbiol. pmid:20890834
Violaris K et al. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. 2010 Am J Perinatol pmid:19504425
te Welscher YM et al. Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. 2010 Antimicrob. Agents Chemother. pmid:20385867
Ogita A et al. Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring. 2010 Int. J. Antimicrob. Agents pmid:19910165
de Aguiar MM et al. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. 2010 Drug Dev Ind Pharm pmid:19954405
Preobrazhenskaya MN et al. Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). 2010 J. Antibiot. pmid:19960041
Bílková E et al. Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. 2010 Int J Pharm pmid:19874880
Shamsul HM et al. The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. 2010 Immunology pmid:20113368
Samaranayake YH et al. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. 2010 Med. Mycol. pmid:20092419
Martínez-Beneyto Y et al. Use of antifungal agents for oral candidiasis: results of a national survey. 2010 Int J Dent Hyg pmid:20096082
Semis R et al. Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. 2010 Mycopathologia pmid:20069459
Ulrych A et al. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. 2010 Eur J Mass Spectrom (Chichester, Eng) pmid:20065516
Young JP et al. Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes. 2010 Am. J. Physiol., Cell Physiol. pmid:20042731
González-Damián J and Ortega-Blake I Effect of membrane structure on the action of polyenes II: nystatin activity along the phase diagram of ergosterol- and cholesterol-containing POPC membranes. 2010 J. Membr. Biol. pmid:20871987
Récamier KS et al. Effect of membrane structure on the action of polyenes: I. Nystatin action in cholesterol- and ergosterol-containing membranes. 2010 J. Membr. Biol. pmid:20872217
Peacock G et al. Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. 2010 Jan-Feb J Am Pharm Assoc (2003) pmid:20097644
Sakeer K et al. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. 2010 Jul-Aug Pharm Dev Technol pmid:19772376
Berger J et al. Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. 2011 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:21123756
Day TP et al. Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. 2011 Mol. Pharm. pmid:21141891
El-Ridy MS et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. 2011 Drug Dev Ind Pharm pmid:21707323
Zerbib C et al. One-pot synthesis of a new antifungal polymerisable monomer and its characterisation by coordination-ion spray mass spectrometry. 2011 Rapid Commun. Mass Spectrom. pmid:21710593
Quarmyne MO et al. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells. 2011 Blood Cells Mol. Dis. pmid:21576026
Huang CY et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. 2011 Mycopathologia pmid:21424606
Mane RS et al. Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. 2011 J. Org. Chem. pmid:21381774
Woods O and Saliba I Effect of nystatin on Guinea Pigs' inner ear. 2011 Neurotox Res pmid:21384237
Schulzke JD et al. Anti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretion. 2011 PLoS ONE pmid:21479205
Chen Y et al. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. 2011 Blood pmid:21482707
Colin D et al. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. 2011 Cancer Prev Res (Phila) pmid:21467134
Shahidi-Noghabi S et al. Internalization of Sambucus nigra agglutinins I and II in insect midgut CF-203 cells. 2011 Arch. Insect Biochem. Physiol. pmid:21254203
Kodedová M et al. Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. 2011 BioTechniques pmid:21231924
Jeon HG et al. Analysis and functional expression of NPP pathway-specific regulatory genes in Pseudonocardia autotrophica. 2011 J. Ind. Microbiol. Biotechnol. pmid:21259033
Wu D et al. Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa. 2011 J Ethnopharmacol pmid:21195154
Stewart AK et al. Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. 2011 Am. J. Physiol., Cell Physiol. pmid:21209359
Orce G et al. β-Cyclodextrin and permeability to water in the bladder of Bufo arenarum. 2011 Can. J. Physiol. Pharmacol. pmid:21609275
Messier C and Grenier D Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. 2011 Mycoses pmid:21615543
Acar A et al. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. 2011 Burns pmid:21354707
Mayercik VA et al. Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. 2011 Arch. Ophthalmol. pmid:21746988
Fan SR and Liu XP In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. 2011 Mycoses pmid:20406393
Frey Tirri B Antimicrobial topical agents used in the vagina. 2011 Curr. Probl. Dermatol. pmid:21325838
Pendela M et al. Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. 2011 J Pharm Biomed Anal pmid:21794999
Daniel SJ et al. Is ototopical nystatin ototoxic? A chinchilla model. 2011 Otolaryngol Head Neck Surg pmid:21860059
Yamasaki M et al. Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro. 2011 J. Parasitol. pmid:21756054
Semis R et al. Activity of an Intralipid formulation of nystatin in murine systemic candidiasis. 2011 Int. J. Antimicrob. Agents pmid:21839619
Valitova JN et al. Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. 2011 Phytochemistry pmid:21726881
Ebert S et al. Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. 2011 Z Gerontol Geriatr pmid:21732154